A detailed history of Bfsg, LLC transactions in Bausch Health Companies Inc. stock. As of the latest transaction made, Bfsg, LLC holds 9,947 shares of BHC stock, worth $64,754. This represents 0.01% of its overall portfolio holdings.

Number of Shares
9,947
Previous 11,450 13.13%
Holding current value
$64,754
Previous $93,000 13.98%
% of portfolio
0.01%
Previous 0.01%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 31, 2025

SELL
$7.34 - $9.78 $11,032 - $14,699
-1,503 Reduced 13.13%
9,947 $80,000
Q2 2024

Jul 29, 2024

BUY
$6.1 - $10.41 $22,222 - $37,923
3,643 Added 46.66%
11,450 $79,000
Q4 2023

Feb 01, 2024

BUY
$6.53 - $8.23 $50,979 - $64,251
7,807 New
7,807 $62,000

Others Institutions Holding BHC

About Bausch Health Companies Inc.


  • Ticker BHC
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 361,728,000
  • Market Cap $2.35B
  • Description
  • Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, O...
More about BHC
Track This Portfolio

Track Bfsg, LLC Portfolio

Follow Bfsg, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bfsg, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bfsg, LLC with notifications on news.